Match!
Sudipa Sarkar
Johns Hopkins University
5Publications
Publications 8
Newest
Source
Source
#1Vincent A. Pallazola (Johns Hopkins University)H-Index: 1
#2Dorothy M. Davis (Johns Hopkins University)
Last.Francine K. Welty (BIDMC: Beth Israel Deaconess Medical Center)H-Index: 37
view all 11 authors...
Abstract Despite continued advances in health care, the cardiovascular disease (CVD) mortality rate has plateaued in recent years and appears to be trending upward. Poor diet is a leading cause of obesity and type 2 diabetes mellitus, which are leading contributors to CVD morbidity and mortality. Although dietary modification is a cornerstone of CVD prevention, implementation in clinical practice is limited by inadequate formal training in nutrition science. In this report, we review the individ...
Source
#1Richard A. Ferraro (Johns Hopkins University)
#2Caitlin M. Nass (JHUSOM: Johns Hopkins University School of Medicine)H-Index: 9
Last.Sudipa Sarkar (Johns Hopkins University)
view all 5 authors...
Abstract The treatment of cardiovascular disease in patients with diabetes has seen a sea change in recent years with the development of novel antihyperglycemic agents. The impact of sodium-glucose cotransporter-2 (SGLT2) inhibitors and glucagon-like peptide-1 receptor agonists (GLP-1 RAs), two medication classes introduced in the United States in the wake of increased scrutiny by the US Food and Drug Administration on cardiovascular disease and antihyperglycemic agents, highlight this progressi...
Source
#1Sudipa Sarkar (Johns Hopkins University)
#2Olusola A. Orimoloye (Johns Hopkins University)H-Index: 3
Last.Seth S. Martin (Johns Hopkins University)H-Index: 32
view all 5 authors...
Current American College of Cardiology/American Heart Association and American Diabetes Association guidelines recommend statin therapy for all patients with diabetes between the ages of 40 and 75, including those without cardiovascular disease (CVD). While diabetes is a major CVD risk factor, not all patients with diabetes have an equal risk of CVD. Thus, a more risk-based approach warrants consideration when recommending statin therapy for the primary prevention of CVD. Coronary artery calcium...
Source
#1Sudipa Sarkar (Johns Hopkins University)
#2Frederick Anokye-Danso (Johns Hopkins University)
Last.Rexford S. Ahima (Johns Hopkins University)H-Index: 3
view all 7 authors...
Background Bariatric surgery is associated with improved cardiovascular outcomes and also affects lipid levels, but few studies have compared the effects of Roux-en-Y gastric bypass (RYGB) surgery with those of laparoscopic sleeve gastrectomy (LSG) on serum fatty acid levels. The present study compares the effects of RYGB and LSG surgeries on serum fatty acid levels.
Source
#1Seamus P. Whelton (Johns Hopkins University)H-Index: 19
#2Jennifer A. Deal (Johns Hopkins University)H-Index: 14
Last.Wendy S. Post (Johns Hopkins University)H-Index: 62
view all 11 authors...
Objective:Whether HIV modifies the relationship of serum lipids with coronary atherosclerosis and coronary plaque subtypes is uncertain. We examined the associations between traditional lipids and coronary atherosclerosis among HIV-infected (HIV+) and HIV-uninfected (HIV−) men.Design:The Multicenter
Source
1